Literature DB >> 11910339

Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure.

Katri Kaukinen1, Leena Halme, Pekka Collin, Martti Färkkilä, Markku Mäki, Paula Vehmanen, Jukka Partanen, Krister Höckerstedt.   

Abstract

BACKGROUND & AIMS: Mild liver abnormalities are common in patients with celiac disease and usually resolve with a gluten-free diet. We investigated the occurrence of celiac disease in patients with severe liver failure.
METHODS: Four patients with untreated celiac disease and severe liver disease are described. Further, the occurrence of celiac disease was studied in 185 adults with previous liver transplantation using serum immunoglobulin A endomysial and tissue transglutaminase antibodies in screening.
RESULTS: Of the 4 patients with severe liver disease and celiac disease, 1 had congenital liver fibrosis, 1 had massive hepatic steatosis, and 2 had progressive hepatitis without apparent origin. Three were even remitted for consideration of liver transplantation. Hepatic dysfunction reversed in all cases when a gluten-free diet was adopted. In the transplantation group, 8 patients (4.3%) had celiac disease. Six cases were detected before the operation: 3 had primary biliary cirrhosis, 1 had autoimmune hepatitis, 1 had primary sclerosing cholangitis, and 1 had congenital liver fibrosis. Only 1 patient had maintained a long-term strict gluten-free diet. Screening found 2 cases of celiac disease, 1 with autoimmune hepatitis and 1 with secondary sclerosing cholangitis.
CONCLUSIONS: The possible presence of celiac disease should be investigated in patients with severe liver disease. Dietary treatment may prevent progression to hepatic failure, even in cases in which liver transplantation is considered.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11910339     DOI: 10.1053/gast.2002.32416

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  73 in total

Review 1.  Celiac disease in pediatric patients with autoimmune hepatitis: etiology, diagnosis, and management.

Authors:  Fabio Panetta; Valerio Nobili; Maria Rita Sartorelli; Raffaele Edo Papa; Francesca Ferretti; Arianna Alterio; Antonella Diamanti
Journal:  Paediatr Drugs       Date:  2012-02-01       Impact factor: 3.022

Review 2.  Association of primary sclerosing cholangitis and celiac disease: a case report and review of the literature.

Authors:  Abdullah M S Al-Osaimi; Carl L Berg
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

3.  Screening for celiac disease in average-risk and high-risk populations.

Authors:  Saurabh Aggarwal; Benjamin Lebwohl; Peter H R Green
Journal:  Therap Adv Gastroenterol       Date:  2012-01       Impact factor: 4.409

Review 4.  Hepatobiliary and pancreatic disorders in celiac disease.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

5.  Liver dysfunction after a gluten-free diet in a patient with celiac disease: a new link?

Authors:  Haldun Selcuk; Mehmet Kanbay; Korkmaz Murat; Ugar Yilmaz
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

6.  Abnormal liver tests as an initial presentation of celiac disease.

Authors:  Michael Sifford; Alvaro Koch; Eun Lee; Luis R Peña
Journal:  Dig Dis Sci       Date:  2007-05-26       Impact factor: 3.199

Review 7.  Celiac disease beyond the gut.

Authors:  Alberto Rubio-Tapia; Joseph A Murray
Journal:  Clin Gastroenterol Hepatol       Date:  2008-06-10       Impact factor: 11.382

8.  Clinical features of chronic C virus hepatitis in patients with celiac disease.

Authors:  M Silano; U Volta; O Vincentini; M De Vincenzi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-06-16       Impact factor: 3.267

9.  A 10-year-old girl with mild elevation of liver transaminases.

Authors:  Rosalyn Díaz; Janice A Kelly; Eduardo Ruchelli; Elizabeth B Rand; Petar Mamula
Journal:  Medscape J Med       Date:  2008-02-05

10.  In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies.

Authors:  I R Korponay-Szabó; T Halttunen; Z Szalai; K Laurila; R Király; J B Kovács; L Fésüs; M Mäki
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.